Global Generic Injectables Market Overview 2018, Demand by Regions, Share, Size and Forecast to 2023

The global generic injectables market has witnessed a healthy growth over the past few years. This can be attributed to the aging population coupled with rapidly increasing cases of chronic diseases and unhealthy lifestyle.

Generic injectables refer to medication which yields the same therapeutic effect as their innovator drugs since they have the similar active ingredients, strength, quality, performance, intended use and dosage. Owing to their low cost, generic injectables have gained popularity in the healthcare sector. Moreover, the number of competitors in the generic injectables market is lower in comparison to oral generics which has resulted in higher profit margins and limited price erosion. A new research report by IMARC Group, titled “Generic Injectables Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2018-2023”, estimates that the market was worth US$ 26.2 Billion in 2017. The report further anticipates the market to reach US$ 45 Billion by 2023, at a projected CAGR of 9.5% over the forecast period.

Global Generic Injectables Market Drivers/Constraints:

• The numerous advantages of generic injectables, including low cost, short approval time and low capital investment compared to brand name injectables are catalysing the generic injectables market across the globe.
• The governments of various countries are supporting the manufacturing of generic injectables as these drugs help to reduce the healthcare costs. This has given an impetus to the market growth.
• Some of the other factors fuelling the growth of the market are the growing geriatric population, patent expiry of a number of drugs, rising prevalence of chronic diseases and an increase in drug shortages.
• The negative perception of the consumers towards generic drugs coupled with stringent regulations laid down by the governments are some of the challenges faced by the global generic injectables market.

Want more information about this market? Request a free report sample

Therapeutic Insights:

On the basis of therapeutic area, oncology accounts for the majority of the global share. The rising concerns over cancer coupled with oncology drugs going off-patent is projected to fuel the growth of this segment. Other major therapeutic areas include anaesthesia, cardiovascular, anti-infectives and parenteral nutrition.

Distribution Channel Insights:

Based on distribution channel, the market has been segmented into hospitals and retail pharmacy stores. Amongst these, hospitals represent the leading segment as generic injectables cannot be administered or traded without medical assistance or permission from a certified practitioner.

Regional Insights:

On a geographical front, the market has been segregated into Asia, North America, Europe, Latin America, and Middle East and Africa. Currently, North America represents the leading market on account of an increase in chronic diseases due to sedentary lifestyle and poor eating habits of the population.

Competitive Landscape:

The market is highly concentrated with the presence of a handful of manufacturers who compete in terms of prices and quality. Some of the leading players operating in the market are:

• Hospira (Pfizer Inc.)
• Fresenius Kabi Ag
• Hikma Pharmaceuticals PLC
• Sandoz (Novartis)
• Sagent Pharmaceuticals, Inc. (Nichi-Iko Pharmaceutical Co. Ltd.)
• Sanofi

Browse related reports:

US Generic Injectables Market Research Report 2018-2023

US Generic Drug Market Research Report 2018-2023

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us

IMARC Group
USA: +1-631-791-1145
Email: sales@imarcgroup.com
Website: https://www.imarcgroup.com
Follow us on twitter: @imarcglobal

Global Anti-Aging Market Overview 2018: Product Types, Region, Growth, Opportunities and Forecast to 2023

The global anti-aging market has been witnessing a positive growth over the past several years. This can be accredited to advancements in technology, a steady rise in aging population and increasing disposable incomes of the consumers.

Request a free sample report: https://www.imarcgroup.com/request?type=report&id=672&flag=B

Aging is brought about by a cycle of various biochemical processes in the body that affect it, both internally and externally. Anti-aging products are designed to reduce or diminish the effects of aging and include powdered supplements, skin creams, and facial masks. A new research report by IMARC Group, titled “Anti-Aging Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2018-2023”, estimates that the market was worth US$ 46.67 Billion in 2017. The report further anticipates the market to cross US$ 72 Billion by 2023, at a projected CAGR of 7.6% over the forecast period.

Global Anti-Aging Market Scenario:

The market has experienced several technological innovations over the past several years. Efforts have been made to enhance the efficacy and safety of the anti-aging products and procedures. Furthermore, manufacturers have been focussing on aggressive marketing strategies, and brand and product endorsements by celebrities, which are also playing a crucial role in influencing consumers and driving the growth of the anti-aging industry.

Market Drivers/Constraints:

• As a result of advancement in the field of medicine, the average life-span of an individual has increased as compared to the earlier times. This has led to a rise in the population of people aged 50 years and above, which is significantly contributing to the demand for anti-aging products.
• With increasing focus on physical appearances, both young and old consumers are seeking out anti-aging and preventive skin and hair care solutions. This trend, coupled with the rising consumer base for quick and effective anti-aging solutions, has boosted the demand for various anti-aging products.
• Due to technological developments, and introduction of safer and more effective anti-aging cosmetics in the market, the consumer-base of these products has rapidly expanded, thereby facilitating the market growth.
• The market is restrained by factors such as high costs of research and development, and manufacturing, strict regulations for manufacturers and the presence of counterfeit products. 

Product Type Insights:

There are a large number of anti-aging products available in the market for the varying needs of the consumers. Currently, anti-wrinkle products dominate the market, accounting for the majority of the total share. They are followed by anti-pigmentation products, sunscreen products and hair care products.

Demographic Insights:

The anti-aging market has been segmented on the basis of key demographic factors such as age, gender and income group. Currently, people belonging to the age group of 35-55-year account for majority of the total consumption, and the market is dominated by females and people belonging to high-income group.

Industry Insights:

Since most signs of aging like wrinkles, cellulite, pigmentation and sagging, start appearing on the skin first, the anti-aging skin care market currently represents the largest industry, holding more than half of the total share. It is followed by anti-aging hair-care industry and anti-aging dental-care industry.

Devices and Technology Insights:

The major devices used for anti-aging procedures include microdermabrasion devices and aesthetic energy devices, which are further classified into radio frequency devices and ultrasound devices.

Regional Insights:

On a geographical front, the United States accounts for the largest share in the global anti-aging market on account of high consumer awareness regarding anti-aging products. The United States is followed by Japan, France, Brazil, Germany, China, South Korea and Italy.

Competitive Landscape:

There is high internal rivalry in the anti-aging industry. With the presence of prominent domestic as well as international players, it is very difficult for a firm to survive in the global anti-aging market. Some of the leading players operating in the market are:

• Allergan
• L’Oréal
• Beiersdorf
• Estee Lauder
• Procter & Gamble
• Shiseido
• Unilever

Browse more related reports

Artificial Organs Market Research Report: https://www.imarcgroup.com/artificial-organs-market

Vision Care Market Research Report: https://www.imarcgroup.com/vision-care-market

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us

IMARC Group
USA: +1-631-791-114
Email: sales@imarcgroup.com
Website: https://www.imarcgroup.com
Follow us on twitter: @imarcglobal

Indian Sanitary Napkin Market – Growth, Share, Opportunities, Industry Analysis And Forecast 2017 To 2022

The Indian sanitary napkin market has been witnessing a positive growth. This is due to various initiatives taken by NGOs, Government and manufacturers to impart education regarding the feminine hygiene and its benefits.

Request a sample report: https://www.imarcgroup.com/request?type=report&id=894&flag=B

The latest report by IMARC Group, titled “Indian Sanitary Napkin Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022”, finds that the Indian sanitary napkin market has reached a value of nearly US$ 414 Million in 2016. Sanitary napkin plays a crucial role in the hygiene and overall health of a woman. It is an absorbent item which is worn inside an undergarment by woman in cases of vaginal surgery recovery, menstruation and post-birth bleeding, etc. The material which is used for the production of sanitary napkin may vary from brand to brand. Sanitary napkin generally comes with or without wings for providing additional protection from leakage.

Highlights of the Indian sanitary napkin market:

• Rising awareness regarding the feminine hygiene is a major growth-inducing factor.
• Disposable menstrual pads represent the largest product type.
• Maharashtra is the leading market, holding the majority of the market share.

The growth of the Indian sanitary napkin market is being majorly driven by a rapid rise in awareness about feminine hygiene. There is also an increase in the number of women in rural areas who are able to afford sanitary napkins at an affordable price. This has, in turn, augmented the demand for sanitary napkins in remote areas. In addition to this, several promotional activities and initiatives have been taken by the Government, NGOs and sanitary napkin manufacturers towards educating women regarding personal hygiene. Another factor which is strengthening the growth of the market is the recent shift towards reusable sanitary napkins owing to the growing environmental concerns. As a result, the Indian sanitary napkin market is further expected to reach a value of around US$ 596 Million, exhibiting a CAGR of more than 6% during 2017-2022.

The market has been segregated on the basis of type as disposable menstrual pads, cloth menstrual pads and biodegradable menstrual pads. Among these disposable menstrual pads exhibit a clear dominance in the market. Based on region, Maharashtra currently accounts for the majority of the total global share. Some of the other major markets include Delhi NCR, Tamil Nadu, Karnataka and Gujarat. The competitive landscape of the market has also been analysed with some of the key players being P&G, Johnson & Johnson, Unicharm and Kimberly-Clark.

Read full report with TOC: https://www.imarcgroup.com/indian-sanitary-napkin-market

The report by IMARC Group has examined the Indian sanitary napkin market on the basis of:

Type:

• Disposable menstrual pads
• Cloth menstrual pads
• Biodegradable menstrual pads

Region:

• Maharashtra
• Delhi NCR
• Tamil Nadu
• Karnataka
• Gujarat

Key Players:

• P&G
• Johnson & Johnson
• Unicharm
• Kimberly-Clark

Browse related reports:

Feminine Hygiene Products Market Research Report: https://www.imarcgroup.com/feminine-hygiene-products-market

Sanitary Napkin Market Market Research Report: https://www.imarcgroup.com/sanitary-napkin-market

Contact Us

IMARC Group
Tel: +1-631-791-1145
Email: sales@imarcgroup.com
Website: https://www.imarcgroup.com
Follow us on twitter: @imarcglobal

Global Intravenous Solutions Market Overview 2018, Demand by Regions, Types and Analysis of Key Players

The global intravenous solutions market has been witnessing a steady growth over the years. This can be accredited to the introduction of new product variants by the manufacturers along with increasing healthcare investments in the developing regions.

Request a free sample report: https://www.imarcgroup.com/request?type=report&id=891&flag=B

The latest report by IMARC Group, titled “Intravenous Solutions Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022”, finds that the global intravenous solution market reached a value of more than US$ 7 Billion in 2016. Intravenous solutions refer to the fluids which are administrated into a vein by means of a steel needle or plastic catheter. They are a combination of essential nutrients that helps in sustaining strength, facilitating faster recovery and maintaining hydration levels in patients. Intravenous solutions also help in the homeostasis of the body by maintaining its fluid and electrolyte balance. In addition to this, they are extensively used by the geriatric population and to treat people suffering from conditions like diabetes and cancer, and unhealthy eating habits.

Highlights of the global intravenous solutions market:

• Portable packaging of intravenous solutions is expected to be the major demand driver.
• North America represents the largest producer, accounting for the majority of the global production.
• The market is projected to reach a value of around US$ 11 Billion by 2022.

The major factor driving the growth of the intravenous solutions market is the availability of intravenous products in portable packaging which makes it easier for consumers to use them in a home setting as well. Additionally, through innovation, vendors are able to offer premixed products for increased convenience and reduced waste and disposal costs which is further likely to impact the market growth. Further, with the rising prevalence of chronic diseases and gastrointestinal disorders, the adoption of intravenous solutions is rising among the consumers. Moreover, the governments in the developing countries are increasing the investment in the healthcare sector, thereby driving the demand for intravenous solutions. According to the report, the global intravenous solutions market is expected to reach a value of around US$ 11 Billion by 2022, exhibiting a CAGR of 6.5% during 2017-2022.

On the basis of product type, the market is segmented into partial and total parenteral nutrition. The market is further segregated on the basis of nutrients into carbohydrates, salts and electrolytes, minerals, vitamins and amino acids. Based on region, North America currently holds the majority of the global intravenous solutions market, followed by Europe and Asia Pacific. Other major regions include the Middle East and Africa, and Latin America. On evaluating the competitive landscape of the market, it is found that the major players are Ajinomoto, B. Braun Melsungen, Baxter International Inc., Grifols and Otsuka Pharmaceutical.

Read full report with TOC: https://www.imarcgroup.com/intravenous-solutions-market

The report by IMARC Group has examined the global intravenous solutions market on the basis of:

Product Type:

• Partial Parenteral Nutrition
• Total Parenteral Nutrition

Nutrients: 

• Carbohydrates
• Salts and Electrolytes
• Minerals
• Vitamins
• Amino Acids

Region: 

• North America
• Europe
• Asia Pacific
• Middle East and Africa
• Latin America

Key Players: 

• Ajinomoto
• B. Braun Melsungen
• Baxter International Inc.
• Grifols
• Otsuka Pharmaceutical

Browse related reports: 

Feminine Hygiene Products Market Research Report: https://www.imarcgroup.com/feminine-hygiene-products-market

Body Contouring Market Research Report: https://www.imarcgroup.com/body-contouring-market

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us

IMARC Group
USA: +1-631-791-1145
Email: sales@imarcgroup.com
Website: https://www.imarcgroup.com
Follow us on twitter: @imarcglobal

Global Body Contouring Market Overview 2017, Demand by Regions, Types and Analysis of Key Players

The global body contouring market has been witnessing positive growth. This can be accredited to various factors such as rising cases of obesity, growing awareness about body contouring, increasing applications as well as technological advancements.

Request a sample report: https://www.imarcgroup.com/request?type=report&id=861&flag=B

The latest report by IMARC Group, titled “Body Contouring Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022”, finds that the global body contouring market reached a value of US$ 5.3 Billion in 2016. Body contouring refers to a group of procedures which alter and contour the shape of body, generally after a significant weight loss. These procedures can be surgical which include arm lifts, breast lifts, stomach lifts, lower body lifts; or non-surgical such as ultrasound therapy, low-level laser therapy, cryolipolysis and suction massage. In the recent years, non-surgical procedures have gained popularity as consumers look for less painful, cost-effective and safer alternatives to get the desired body shape.

Highlights of the global body contouring market:

• The growing trend of ‘quick-fix’, particularly in the western regions is one of the major growth-inducing drivers.
• Clinical research organisations represent the largest end-use sector. 
• North America represents the largest market for body contouring.

One of the major factors catalysing the market growth is the heightened importance given to physical appearance amongst a large section of the population. This coupled with the escalating trend of ‘quick-fix’, particularly in the western regions, is propelling the growth of the global body contouring market. Additionally, increasing cases of obesity and growing awareness about body contouring is broadening the growth prospects of the market. Moreover, the advancements in the technology, such as ultrasound cavitation, mesotherapy, infra-red technology, laser-lypolysis, radio-frequency therapy, dynamic pulse control (DPC) and intense pulse light (IPL), have facilitated the market growth. As a result, the global body contouring market is further expected to reach a value of US$ 8 Billion, exhibiting a CAGR of 7% during 2017-2022.

On the basis of invasiveness, non-invasive devices currently exhibit a clear dominance in the market, followed by minimally invasive and invasive devices. Based on end-use sector, clinical research organisations represent the largest end-use sector of body contouring on account of continuous technological developments. It is followed by hospitals, medical spas and clinics. Region-wise, North America currently accounts for the majority of the total global share. This is due to the wide availability of facilities for the procedures and a large consumer-base. Other major regions include Europe, Asia Pacific, Latin America, and Middle East and Africa. The competitive landscape of the market has also been analysed with some of the key players operating in the market being Cynosure, Meridian, Syneron Medical Ltd., Lumenis, and Alma Lasers.

Read full report with TOC: https://www.imarcgroup.com/body-contouring-market

The report by IMARC Group has examined the global body contouring market on the basis of:

Invasiveness:

• Non-invasive
• Minimally invasive

End-Use:

• Clinical Research Organizations
• Hospitals
• Medical Spas
• Clinics

Region:

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

Major manufacturers:

• Cynosure
• Meridian
• Syneron Medical Ltd.
• Lumenis
• Alma Lasers

Browse related reports:

Artificial Organs Market Research Report: https://www.imarcgroup.com/artificial-organs-market

Exercise Bike Market Research Report: https://www.imarcgroup.com/exercise-bike-market

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us

IMARC Group
USA: +1-631-791-1145
Email: sales@imarcgroup.com
Website: https://www.imarcgroup.com
Follow us on twitter : @imarcglobal

US Generic Drug Market 2017 - Teva, Mylan, Actavis, Sandoz, Sun Pharma, Par Pharmaceuticals

The US generic drug market has witnessed a steady growth in the recent years. The major factors that have added to the market growth are low investment in R&D, patent expiry of innovative drugs and cost-effectiveness of generic drugs as compared to their counterparts.

Request a free sample copy of the report: www.imarcgroup.com/request?type=report&id=567&flag=B

The latest report by IMARC Group, titled “US Generic Drug Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022”, finds that the US generic drug market reached a value of nearly 4 Million prescriptions in 2016, exhibiting a CAGR of 5% during 2010-2016. Over the past several years, the United States has undergone a major transformation in the pharmaceutical sector. Nearly, 80% of the total prescription drugs in the US consist of generic drugs. They are low-cost versions of the innovator drugs with same dosage, strength, risks, effects, side-effects and intended usage. Generic drugs assure that the medicines are effective and safe for the consumers. These drugs come in different forms such as oral, nebulizer, intravenous, topical and intramuscular.

Highlights of the US generic drug market:

• Upcoming patent expiry of branded drugs is projected to boost the market growth.
• With low manufacturing costs, these drugs are comparatively cheaper than innovative drugs.
• Teva represents the leading manufacturer of generic drugs in the US.

Generic drugs can only be launched by the manufacturers once the branded drugs go off-patent. Imminent patent expiry of a huge number of blockbuster innovator drugs is expected to be one of the major factors contributing to the market growth. Moreover, generic drugs require less effort in the research & development sector, thus the cost involved in the manufacturing of these drugs are lower than the branded drugs. Owing to this, generic drugs are cheaper in comparison to their counterparts, thereby making them affordable for different income groups. This helps in reducing the healthcare expenditures of the government, patients and third-party payers. Additionally, the fact that the US pharmacists are paid incentives to prescribe cheaper generic drugs has further stimulated the market growth. Other major factors fueling the growth of the market include ageing population and prevalence of chronic diseases. According to the report, the market is anticipated to reach a value of around 5 Million prescriptions by 2022.

Read full report with TOC @ www.imarcgroup.com/us-generics-market

The US generic drug market is segmented into branded and unbranded generics. Presently, unbranded generic drugs are leading the market, holding for the majority of the total generic prescription volumes. On comparing the competitive landscape of the market, the key players found are Teva, Mylan, Actavis, Sandoz, Sun Pharma, Par Pharmaceuticals, Endo Pharmaceuticals, Lupin Pharmaceuticals, Dr Reddy’s and Hospira. Among these, Teva represents the leading generic manufacturer in the US, accounting for around a fifth of the total generic sales.

Browse related reports :
GCC Generic Drug Market: www.imarcgroup.com/gcc-generic-drug-market

US Generic Injectables Market: www.imarcgroup.com/us-generic-injectables-market

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.Global Cigarette Lighter Market

Contact us

IMARC Group
309 2nd St, Brooklyn, NY 11215, USAWebsite: www.imarcgroup.com
Email: sales@imarcgroup.com
USA: +1-631-791-1145
Follow us on twitter: @imarcglobal

Global Cataract Surgical Devices Market 2017: Region Wise Analysis of Top Players in Market By Types and Application

The global cataract surgical devices market has witnessed a steady growth over the years. This can be accredited to the availability of a wide range of modern and innovative ophthalmic devices coupled with an ageing population.

Request sample report: http://www.imarcgroup.com/request?type=report&id=840&flag=B

The latest report by IMARC Group, titled “Cataract Surgical Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022”, finds that the global cataract surgical devices market reached a value of nearly US$ 7 Billion in 2016. Cataract is an eye disease in which things appear blurry, hazy or less colourful, resulting in cloudy or opaque vision. It can be caused due to ageing, diabetes, smoking, trauma or prolonged exposure to sunlight. Cataract can be removed using certain surgical instruments and devices, such as ophthalmic viscoelastic devices, drapes, gloves, balanced salt solution, forceps, irrigation set, and intraocular lenses. These devices are safe and help in effectively restoring vision to the eye.

Highlights of the global cataract surgical devices market:

• Rapid increase in the prevalence of ocular disorders is the key factor driving the growth of the market.
• Intraocular lenses are the most popular product type, holding the largest share.
• North America represents the largest market, accounting for the majority of the global share.

A rise in the geriatric population worldwide in confluence with growing prevalence of ocular diseases and technological advancements in the healthcare sector represent the major factors influencing the cataract surgical devices market. On the other hand, a lack of awareness among the individuals regarding the benefits of cataract surgeries along with low healthcare insurance coverage impede the growth of the cataract surgical devices market in the emerging regions. However, the governments of numerous countries are introducing healthcare programmes to reduce the burden of cataract-related diseases on the patients, further creating profitable opportunities for the manufacturers. Owing to these factors, the global cataract surgical devices market is further expected to reach a value of around US$ 9 Billion by 2022, exhibiting a CAGR of nearly 4% during 2017-2022.

The market is segmented on the basis of product type into Intraocular Lenses (IOLs), femtosecond laser, Ophthalmic Viscoelastic Devices (OVDs), phacoemulsification equipment and others. Currently, IOLs represent the most popular product type, accounting for the majority of the market share. On the basis of application, the market is segregated in hospitals, eye care clinics, and eye treatment and surgical centres, wherein hospital accounts for the largest share. On a regional basis, North America currently accounts for the largest share. Other major regions include Europe, Asia Pacific, Latin America, and Middle East and Africa. On evaluating the competitive landscape of the market, it is found that the global players are Abbott Laboratories, Hoya Corporation, Carl Zeiss Meditec, Alcon Laboratories, Inc., and Essilor.

Read full report with TOC: http://www.imarcgroup.com/cataract-surgical-devices-market

The report by IMARC Group has examined the global cataract surgical devices market on the basis of:

Product Type:

• Intraocular Lenses (IOLs) 
• Femtosecond laser 
• Ophthalmic Viscoelastic Devices (OVDs)
• Phacoemulsification Equipment 

Application:

• Hospitals
• Eye Care Clinics
• Eye Treatment and Surgical Centres

Region:

•  North America
•  Europe
•  Asia Pacific
•  Latin America
•  Middle East and Africa

Key Players:

• Abbott Laboratories
• Hoya Corporation
• Carl Zeiss Meditec
• Alcon Laboratories, Inc
• Essilor

Browse related reports:

Eyewear Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022

Vision Care Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us

IMARC Group
USA: +1-631-791-1145
Email: sales@imarcgroup.com
Website: http://www.imarcgroup.com
Follow us on twitter: @imarcglobal